Cargando…
Retraction
Tong L, Ao Y, Zhang H, Wang K, Wang Y, Ma Q. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR‐155‐5p. Cancer Med. 2019;8:4782–4791. https://doi.org/10.1002/cam4.2350 The above article, published online...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225215/ https://www.ncbi.nlm.nih.gov/pubmed/37046403 http://dx.doi.org/10.1002/cam4.5822 |
| _version_ | 1785050352493527040 |
|---|---|
| collection | PubMed |
| description | Tong L, Ao Y, Zhang H, Wang K, Wang Y, Ma Q. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR‐155‐5p. Cancer Med. 2019;8:4782–4791. https://doi.org/10.1002/cam4.2350 The above article, published online on 28 June 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Dr Stephen Tait and John Wiley and Sons Ltd. The retraction has been agreed due to scientific inconsistences invalidating the conclusions presented. |
| format | Online Article Text |
| id | pubmed-10225215 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102252152023-05-29 Retraction Cancer Med Retraction Tong L, Ao Y, Zhang H, Wang K, Wang Y, Ma Q. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR‐155‐5p. Cancer Med. 2019;8:4782–4791. https://doi.org/10.1002/cam4.2350 The above article, published online on 28 June 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief, Dr Stephen Tait and John Wiley and Sons Ltd. The retraction has been agreed due to scientific inconsistences invalidating the conclusions presented. John Wiley and Sons Inc. 2023-04-12 /pmc/articles/PMC10225215/ /pubmed/37046403 http://dx.doi.org/10.1002/cam4.5822 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Retraction |
| title | Retraction |
| title_full | Retraction |
| title_fullStr | Retraction |
| title_full_unstemmed | Retraction |
| title_short | Retraction |
| title_sort | retraction |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225215/ https://www.ncbi.nlm.nih.gov/pubmed/37046403 http://dx.doi.org/10.1002/cam4.5822 |